Xempox Tablet is a combination medication containing Mebeverine 135 mg and Chlordiazepoxide 5 mg, formulated for the management of irritable bowel syndrome (IBS) and related gastrointestinal disorders characterized by abdominal pain, cramping, and altered bowel habits. Mebeverine acts as a smooth muscle relaxant with antispasmodic properties, targeting the gastrointestinal tract to alleviate muscle spasms without affecting normal gut motility. Chlordiazepoxide, a benzodiazepine derivative, provides anxiolytic and mild sedative effects, which help reduce anxiety-related symptoms often associated with functional bowel disorders. The synergistic action of these two active ingredients helps in relieving abdominal discomfort and associated psychological stress, improving overall patient well-being. Xempox is typically administered orally, with dosage individualized based on clinical response and tolerability. It is contraindicated in patients with hypersensitivity to its components, severe hepatic or renal impairment, and should be used cautiously in individuals with a history of substance abuse or respiratory depression. Common side effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. Patients are advised to avoid alcohol consumption during therapy and consult healthcare providers before initiating treatment to ensure safe and effective use.